Adrenal disease

Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Both elevated NLR and PLR are associated with poor prognosis in PPGLs. They are convenient predictive markers that could be used in daily clinical practice.

Study context

Population
Consecutive patients with PPGL, 2002–20201,247 evaluated
Participants
728 patients
Exposure
High vs low preoperative neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR)
Outcome
Death
Follow-up
Median 63 months (IQR, 31-111 months)
Methodological detailsconsecutive patients, Cut-offs by X-tile software; Kaplan-Meier curves and Cox regression models
  • Consecutive patients
  • Cut-offs by X-tile software; Kaplan-Meier curves and Cox regression models

Main finding

As reported in the abstract

Deaths

31

Developed metastases

28

Developed recurrence

12

Observational data: associations, not effects.

Further findings

Overall survival (OS)

Elevated NLR (≥3.5) and elevated PLR (≥217.4) associated with decreased OS
P = 0.005
NLR and PLR independent prognostic factors for OS (Cox models)

Metastasis-free survival

Elevated PLR (≥238.3) associated with decreased metastasis-free survival (MFS)
P = 0.021
PLR independent prognostic factor for MFS (Cox models)

Original publication

Platelet-Lymphocyte and Neutrophil-Lymphocyte Ratios Are Prognostic Markers for Pheochromocytomas and Paragangliomas. J Clin Endocrinol Metab. Published 14 March 2023. doi:10.1210/clinem/dgad149

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.